Low DYRK2 expression, older age, TNM stages (especially later TNM, T, or N stages), and high preoperative carcinoembryonic antigen levels correlate with poor five-year survival rates in patients with gastric cancer [25]. This evidence concerns the gene DYRK2 and gastric cancer.